Clinical trial / 2004
Hibiscus sabdariffa extract decreased blood pressure similarly to captopril in hypertensive patients.
Seventy-five adults with mild to moderate hypertension completed a four-week trial comparing a daily Hibiscus sabdariffa infusion (9.6 mg anthocyanins) with captopril (25 mg twice daily). Hibiscus intake reduced systolic blood pressure from 139.05 to 123.73 mm Hg (p < 0.03) and diastolic pressure from 90.81 to 79.52 mm Hg (p < 0.06). Final blood pressure, therapeutic effectiveness rates (0.7895 versus 0.8438), and 100% tolerability did not differ significantly between treatments.
- Study type
- Randomized controlled trial
- Who was studied
- 75 adults aged 30 to 80 with mild to moderate hypertension
- What was measured
- Blood pressure reduction and therapeutic effectiveness
THE PAPER
Effectiveness and tolerability of a standardized extract from Hibiscus sabdariffa in patients with mild to moderate hypertension: a controlled and randomized clinical trial.
Herrera-Arellano A, Flores-Romero S, Chávez-Soto MA, Tortoriello J. Phytomedicine, 2004.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.